Related Experiment Video
Updated: Jul 5, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
An Endovascular- Versus a Surgery-First Revascularization Strategy for Chronic Limb-Threatening Ischemia: A
Syed Hamza Mufarrih1, Mohammad Saud Khan2, Nada Qaisar Qureshi1
1Department of Medicine, University of Kentucky, Bowling Green, Kentucky.
Insights
For chronic limb-threatening ischemia (CLTI), this meta-analysis found no significant difference in outcomes between endovascular-first and surgery-first revascularization strategies. Both approaches offer comparable limb salvage and survival rates for CLTI patients.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Meta-Analysis
Background:
- Chronic limb-threatening ischemia (CLTI) necessitates timely revascularization for limb salvage and mortality reduction.
- The optimal revascularization strategy (endovascular-first vs. surgery-first) for CLTI patients eligible for both remains uncertain.
- Conflicting results from recent randomized controlled trials (RCTs) highlight the need for further comparative analysis.
Purpose of the Study:
- To conduct a trial-level meta-analysis comparing clinical outcomes of endovascular-first versus surgery-first revascularization strategies in patients with CLTI.
- To synthesize evidence from RCTs to inform clinical decision-making regarding revascularization approaches for CLTI.
Main Methods:
- A systematic literature search was performed across PubMed, Web of Science, and the Cochrane Library to identify relevant RCTs.
- Data from 3 RCTs, including 2,627 CLTI patients, were pooled using a random-effects model to calculate aggregate risk ratios (RRs) and hazard ratios (HRs).
- Outcomes analyzed included overall survival, amputation-free survival, reintervention rates, major amputation, and therapeutic crossover up to 5 years.
Main Results:
- No significant differences were observed between endovascular-first and surgery-first strategies regarding overall survival (HR 0.92 [0.83 to 1.01]) or amputation-free survival (HR 0.98 [0.92 to 1.03]).
- Rates of reintervention (RR 1.24 [0.74 to 2.07]), major amputation (RR 1.16 [0.87 to 1.54]), and therapeutic crossover (RR 0.92 [0.37 to 2.26]) also showed no statistically significant differences.
- The study included a substantial number of patients (2,627) with a majority being male (70.9%) and a notable proportion over 80 years old (13.2%).
Conclusions:
- Current evidence from RCTs suggests that neither an endovascular-first nor a surgery-first approach offers a significant advantage in clinical outcomes for CLTI patients.
- The findings indicate comparable efficacy between the two revascularization strategies in terms of limb salvage and survival.
- A future patient-level meta-analysis is recommended to provide more granular insights into treatment effectiveness for CLTI.
Abstract:
Timely revascularization is essential for limb salvage and to reduce mortality in patients with chronic limb-threatening ischemia (CLTI). In patients who are candidates for endovascular therapy and surgical bypass, the optimal revascularization strategy remains uncertain. Recently published randomized controlled trials (RCTs) have presented conflicting results. We conducted a trial-level meta-analysis to compare the outcomes between endovascular-first and surgery-first strategies for revascularization. PubMed, Web of Science, and the Cochrane Library were searched to identify RCTs comparing the outcomes of endovascular-first versus surgery-first strategies for revascularization in patients with CLTI. Data were pooled for major outcomes and their aggregate risk ratios (RRs) with 95% confidence intervals were calculated using a random-effects model. Kaplan-Meier curves for amputation-free survival and overall survival time were plotted using the pooled aggregated data from published curves, with their corresponding hazard ratios (HRs) and 95% confidence intervals reported for up to 5 years of follow-up. A total of 3 RCTs with 2,627 patients (1,312 endovascular-first and 1,315 surgery-first) were included in the meta-analysis. Of these, 1,864 patients (70.9%) were men and 347 (13.2%) were older than 80 years. Comparing the endovascular-first and surgery-first approaches, there was no significant difference in the overall (HR 0.92 [0.83 to 1.01], p = 0.09) or amputation-free survival (HR 0.98 [0.92 to 1.03], p = 0.42), reintervention (RR 1.24 [0.74 to 2.07], p = 0.41), major amputation, (RR 1.16 [0.87 to 1.54], p = 0.31), or therapeutic crossover (RR 0.92 [0.37 to 2.26], p = 0.85). In conclusion, data from available RCTs suggest that there is no difference in clinical outcomes between endovascular-first and surgery-first revascularization strategies for CLTI. A planned patient-level meta-analysis may provide further insight.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023